Order of patient entry and outcomes in phase II clinical trials: A meta-analysis of individual patient data.

Behrendt, Carolyn E; Villalona-Calero, Miguel A; Newman, Edward M; Frankel, Paul H

Behrendt, Carolyn E; Villalona-Calero, Miguel A; Newman, Edward M; Frankel, Paul H.

Affiliation

Behrendt CE; Division of Biostatistics, Department of Computational and Quantitative Medicine, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address: CarolynBehrendt77@gmail.com.
Villalona-Calero MA; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address: mvillalona@coh.org.
Newman EM; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address: edwardmnewman@gmail.com.
Frankel PH; Division of Biostatistics, Department of Computational and Quantitative Medicine, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address: pfrankel@coh.org.

Contemp Clin Trials ; 125: 107083, 2023 02.

Article de En | MEDLINE | ID: mdl-36638911

Sujet(s)
Mots clés

Disease progression; Early discontinuation; Entry rank; Phase II trials; Survival; Toxicity

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Néphrocarcinome / Essais cliniques de phase II comme sujet / Sélection de patients / Transplantation de cellules souches Type d'étude: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limites: Humans Langue: En Journal: Contemp Clin Trials Sujet du journal: MEDICINA / TERAPEUTICA Année: 2023 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google